Published • loading... • Updated
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
The collaboration leverages AI and human data to identify new atopic disease targets with up to $1.7 billion in potential milestones, aiming to reduce clinical failure risk.
Summary by Hastings Tribune
5 Articles
5 Articles
Reposted by
Globe Newswire
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Relation today announced a multi-program, strategic collaboration with Novartis to discover and advance novel targets for atopic diseases.
The Swiss pharmaceutical company Novartis has reached an agreement this Tuesday valued at up to 1.7 billion dollars (1,461 million euros) with the British laboratory Relation Therapeutics pa ...
Coverage Details
Total News Sources5
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium

